Drug Profile
Ascosteroside
Alternative Names: L 767812Latest Information Update: 15 Jan 2008
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Antifungals; Cholestanes
- Mechanism of Action Glucan synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Mycoses
Most Recent Events
- 30 Apr 1999 No-Development-Reported for Mycoses in USA (Unknown route)
- 29 Aug 1996 New profile
- 29 Aug 1996 Preclinical development for Mycoses in USA (Unknown route)